Tag: Respircardia
Sleep therapy system receives $58.5M in funding
December 19, 2017HME News Staff
MINNETONKA, Minn. - The makers of a transvenous implantable neurostimulation system for treating central sleep apnea have received $58.5 million in financing. The financing for Respicardia and its remed? System was led by ZOLL Medical Corp., a manufacturer of medical devices and related software solutions. "We believe the remed? System will soon become the treatment of choice for patients suffering from central sleep apnea," stated Bonnie Labosky, president and CEO of Respicardia. "Proceeds from...
Funding, Respircardia, Sleep Therapy
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office